AKBA
Akebia Therapeutics Inc [AKBA] Revenue clocked in at $225.07 million, down -14.44% YTD: What’s Next?
Edison Baldwin
Akebia Therapeutics Inc [NASDAQ: AKBA] price plunged by -3.14 percent to reach at -$0.05. A sum of 3906022 shares traded ...
why Akebia Therapeutics Inc [AKBA] is a Good Choice for Investors After New Price Target of $5.80
Annabelle Farmer
Akebia Therapeutics Inc [NASDAQ: AKBA] closed the trading session at $1.67 on 2025-11-10. The day’s price range saw the stock ...
H.C. Wainwright slashes price target on Akebia Therapeutics Inc [AKBA] – find out why.
Edison Baldwin
Akebia Therapeutics Inc [NASDAQ: AKBA] loss -32.04% or -0.99 points to close at $2.1 with a heavy trading volume of ...
